Your browser doesn't support javascript.
loading
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.
Liu, Xiaolei; Devadiga, Sudhish A; Stanley, Robert F; Morrow, Ryan M; Janssen, Kevin A; Quesnel-Vallières, Mathieu; Pomp, Oz; Moverley, Adam A; Li, Chenchen; Skuli, Nicolas; Carroll, Martin; Huang, Jian; Wallace, Douglas C; Lynch, Kristen W; Abdel-Wahab, Omar; Klein, Peter S.
Affiliation
  • Liu X; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Devadiga SA; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Stanley RF; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Morrow RM; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Janssen KA; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Quesnel-Vallières M; Department of Biochemistry and Biophysics and.
  • Pomp O; Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Moverley AA; Department of Cell and Developmental Biology, Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Li C; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Skuli N; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Carroll M; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Huang J; Coriell Institute for Medical Research, Camden, New Jersey, USA.
  • Wallace DC; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Lynch KW; Department of Pediatrics, Division of Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Abdel-Wahab O; Department of Biochemistry and Biophysics and.
  • Klein PS; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Clin Invest ; 134(12)2024 May 07.
Article de En | MEDLINE | ID: mdl-38713535
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein kinases / Leucémie aigüe myéloïde / Mitophagie / Facteurs d'épissage riches en sérine-arginine / Mitochondries Limites: Animals / Humans Langue: En Journal: J Clin Invest Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protein kinases / Leucémie aigüe myéloïde / Mitophagie / Facteurs d'épissage riches en sérine-arginine / Mitochondries Limites: Animals / Humans Langue: En Journal: J Clin Invest Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique